Viewing Study NCT04051606


Ignite Creation Date: 2025-12-26 @ 2:42 PM
Ignite Modification Date: 2025-12-26 @ 2:42 PM
Study NCT ID: NCT04051606
Status: COMPLETED
Last Update Posted: 2025-06-05
First Post: 2019-08-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
Sponsor: Case Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module